These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38727899)

  • 21. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
    Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
    Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
    Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ
    Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.
    Tarabeux J; Kebir O; Gauthier J; Hamdan FF; Xiong L; Piton A; Spiegelman D; Henrion É; Millet B; ; Fathalli F; Joober R; Rapoport JL; DeLisi LE; Fombonne É; Mottron L; Forget-Dubois N; Boivin M; Michaud JL; Drapeau P; Lafrenière RG; Rouleau GA; Krebs MO
    Transl Psychiatry; 2011 Nov; 1(11):e55. PubMed ID: 22833210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential functional consequences of GRIN2A mutations associated with schizophrenia and neurodevelopmental disorders.
    Shepard N; Baez-Nieto D; Iqbal S; Kurganov E; Budnik N; Campbell AJ; Pan JQ; Sheng M; Farsi Z
    Sci Rep; 2024 Feb; 14(1):2798. PubMed ID: 38307912
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Platzer K; Yuan H; Schütz H; Winschel A; Chen W; Hu C; Kusumoto H; Heyne HO; Helbig KL; Tang S; Willing MC; Tinkle BT; Adams DJ; Depienne C; Keren B; Mignot C; Frengen E; Strømme P; Biskup S; Döcker D; Strom TM; Mefford HC; Myers CT; Muir AM; LaCroix A; Sadleir L; Scheffer IE; Brilstra E; van Haelst MM; van der Smagt JJ; Bok LA; Møller RS; Jensen UB; Millichap JJ; Berg AT; Goldberg EM; De Bie I; Fox S; Major P; Jones JR; Zackai EH; Abou Jamra R; Rolfs A; Leventer RJ; Lawson JA; Roscioli T; Jansen FE; Ranza E; Korff CM; Lehesjoki AE; Courage C; Linnankivi T; Smith DR; Stanley C; Mintz M; McKnight D; Decker A; Tan WH; Tarnopolsky MA; Brady LI; Wolff M; Dondit L; Pedro HF; Parisotto SE; Jones KL; Patel AD; Franz DN; Vanzo R; Marco E; Ranells JD; Di Donato N; Dobyns WB; Laube B; Traynelis SF; Lemke JR
    J Med Genet; 2017 Jul; 54(7):460-470. PubMed ID: 28377535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
    Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
    Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional effects of disease-associated variants reveal that the S1-M1 linker of the NMDA receptor critically controls channel opening.
    Xie L; McDaniel MJ; Perszyk RE; Kim S; Cappuccio G; Shapiro KA; Muñoz-Cabello B; Sanchez-Lara PA; Grand K; Zhang J; Nocilla KA; Sheikh R; Armengol L; Romano R; Pierson TM; Yuan H; Myers SJ; Traynelis SF
    Cell Mol Life Sci; 2023 Mar; 80(4):110. PubMed ID: 37000222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
    Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
    Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epilepsy in patients with GRIN2A alterations: Genetics, neurodevelopment, epileptic phenotype and response to anticonvulsive drugs.
    von Stülpnagel C; Ensslen M; Møller RS; Pal DK; Masnada S; Veggiotti P; Piazza E; Dreesmann M; Hartlieb T; Herberhold T; Hughes E; Koch M; Kutzer C; Hoertnagel K; Nitanda J; Pohl M; Rostásy K; Haack TB; Stöhr K; Kluger G; Borggraefe I
    Eur J Paediatr Neurol; 2017 May; 21(3):530-541. PubMed ID: 28109652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
    Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
    PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-methyl-d-aspartate (NMDA) receptor genetics: The power of paralog homology and protein dynamics in defining dominant genetic variants.
    Charron JG; Hernandez A; Bilinovich SM; Vogt DL; Bedinger LA; Seaver LH; Williams M; Devries S; Campbell DB; Bupp CP; Prokop JW
    Am J Med Genet A; 2022 Feb; 188(2):556-568. PubMed ID: 34726335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunotherapy for GRIN2A and GRIN2D-related epileptic encephalopathy.
    Hausman-Kedem M; Menascu S; Greenstein Y; Fattal-Valevski A
    Epilepsy Res; 2020 Jul; 163():106325. PubMed ID: 32289570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploratory study of selected nucleotide variants in GRIN1, GRIN2A and GRIN2B encoding subunits of the NMDA receptor in a targeted group of schizophrenia patients with chronic cognitive impairment.
    Krzystanek M; Asman M; Witecka J; Pałasz A; Wiaderkiewicz R
    Pharmacol Rep; 2021 Feb; 73(1):269-277. PubMed ID: 33237434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential responses of disease-related GRIN variants located in pore-forming M2 domain of N-methyl-D-aspartate receptor to FDA-approved inhibitors.
    Song R; Zhang J; Perszyk RE; Camp CR; Tang W; Kannan V; Li J; Xu Y; Chen J; Li Y; Liang SH; Traynelis SF; Yuan H
    J Neurochem; 2023 Aug; ():. PubMed ID: 37649269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of memantine use in a pediatric neurology clinic.
    Bouhadoun S; Poulin C; Berrahmoune S; Myers KA
    Brain Dev; 2021 Nov; 43(10):997-1003. PubMed ID: 34074563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of Grin2a causes a transient delay in the electrophysiological maturation of hippocampal parvalbumin interneurons.
    Camp CR; Vlachos A; Klöckner C; Krey I; Banke TG; Shariatzadeh N; Ruggiero SM; Galer P; Park KL; Caccavano A; Kimmel S; Yuan X; Yuan H; Helbig I; Benke TA; Lemke JR; Pelkey KA; McBain CJ; Traynelis SF
    Commun Biol; 2023 Sep; 6(1):952. PubMed ID: 37723282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional Evaluation of a De Novo
    Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
    Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compound-heterozygous GRIN2A null variants associated with severe developmental and epileptic encephalopathy.
    Strehlow V; Rieubland C; Gallati S; Kim S; Myers SJ; Peterson V; Ramsey AJ; Teuscher DD; Traynelis SF; Lemke JR
    Epilepsia; 2022 Oct; 63(10):e132-e137. PubMed ID: 35983985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conserved patterns across ion channels correlate with variant pathogenicity and clinical phenotypes.
    Brünger T; Pérez-Palma E; Montanucci L; Nothnagel M; Møller RS; Schorge S; Zuberi S; Symonds J; Lemke JR; Brunklaus A; Traynelis SF; May P; Lal D
    Brain; 2023 Mar; 146(3):923-934. PubMed ID: 36036558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
    Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
    Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.